Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET

Company Participants

Tram Bui - Vice President, Investor Relations & Corporate Communication

Helen Torley - President & Chief Executive Officer

Nicole LaBrosse - Chief Financial Officer

Conference Call Participants

Michael DiFiore - Evercore ISI

Jessica Fye - JPMorgan

David Risinger - SVB Securities

Jason Butler - JMP

Corinne Jenkins - Goldman Sachs

Operator

Good afternoon. My name is Shantou, and I will be your conference operator today. At this time, I would like to welcome everyone to the Halozyme Third Quarter 2022 Financial and Operating Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions] Please note, this event is being recorded.

I will now turn the call over to Tram Bui, Halozyme's Vice President, Investor Relations and Corporate Communications. Please go ahead.

Tram Bui

Thank you, operator. Good afternoon, and welcome to our third quarter 2022 financial and operating results conference call. In addition to our press release issued today after the market close, you could find a supplementary slide presentation that will be referenced during today's call in the Investor Relations section of our website.

Leading the call will be Dr. Helen Torley, Halozyme's President and Chief Executive Officer, who will provide an update on our business; and Nicole LaBrosse, our Chief Financial Officer, who will review our financial results for the third quarter ended September 30th, 2022.

On today's call, we will be making forward-looking statements. I refer you to our SEC filings for a full list of risk and uncertainties. During the call, both GAAP and non-GAAP financial measures will be discussed. The non-GAAP or adjusted financial measures are reconciled with the comparable GAAP financial measures in our earnings press release and slide presentation.

I'll now turn the call over to Helen Torley.

Helen Torley

Thank you, Tram, and good afternoon, everyone. I am pleased that our third quarter results continue to reflect both strong financial and operational performance across the business. I'll begin on slide 3 and what is excellent news. I'm delighted to announce that we achieved an all-time high quarterly royalty revenue of almost $100 million in the third quarter. This represents strong growth of 70% over prior year third quarter, and continues to demonstrate the strength of all of our ENHANZE business.